Competing Interests: Vancomycin Use in Trauma Patients is Similar During Methicillin-Resistant <i>Staphylococcus aureus</i> Nasal Swab Based De-Escalation and Universal Mupirocin Decolonization Protocols

<b><i>Introduction:</i></b> Protocols for vancomycin de-escalation often rely on nasal swab testing for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). However, in settings of hospital-wide universal MRSA decolonization with nasal mupirocin, these swabs may be unreliable, hindering de-escalation protocols. This study investigated vancomycin use and MRSA infection in trauma patients managed under each of these separate protocols. <b><i>Methods:</i></b> This retrospective review compared patients admitted to a Level 1 trauma center during a time-period of MRSA swab-based vancomycin de-escalation ("de-esc") with those admitted during a subsequent period of universal decolonization (and thus "no de-esc"). The primary outcome was total days of vancomycin per patient receiving vancomycin. Additional outcomes included a proportion of patients receiving a short course of vancomycin (<3 d), overall vancomycin rates, and in-hospital MRSA infections. <b><i>Results:</i></b> A total of 5,678 patients were evaluated, with 2,891 admitted during the "de-esc" period and 2,787 admitted during universal decolonization ("no de-esc"). There was no difference in the proportion of patients receiving vancomycin during the "de-esc" versus "no de-esc" protocols (7.2% [n = 208] vs. 6.5% [n = 181], p = 0.3). Among these patients, there was also no difference in either total days of vancomycin (5.3 d vs. 5.9 d, p = 0.3) or proportion receiving a short vancomycin course (33% vs. 29%, p = 0.5). There were 56 total patients with MRSA infections, with no difference between the two time periods (1.1% vs. 0.7%, p = 0.07). <b><i>Conclusion:</i></b> Despite concerns that a hospital-wide MRSA universal decolonization policy would hinder nasal swab-based vancomycin de-escalation, both vancomycin use and MRSA infection rates remained the same during the two time periods.

Authors

Institutions

Publication Details

Journal
Surgical Infections
Published
2025-04-04
DOI
https://doi.org/10.1089/sur.2024.280
Primary Topic
Antimicrobial Resistance in Staphylococcus
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Competing Interests: Vancomycin Use in Trauma Patients is Similar During Methicillin-Resistant Staphylococcus aureus Nasal Swab Based De-Escalation and Universal Mupirocin Decolonization Protocols

Jennifer R. Beavers, Shayan Rakhit, Robel Beyene, Leanne Atchison et al.
3 links
Surgical Infections
Antimicrobial Resistance in Staphylococcus
article

Competing Interests: Vancomycin Use in Trauma Patients is Similar During Methicillin-Resistant Staphylococcus aureus Nasal Swab Based De-Escalation and Universal Mupirocin Decolonization Protocols

Jennifer R. Beavers, Shayan Rakhit, Robel Beyene, Leanne Atchison, Elizabeth D. Krebs
article en

Abstract

<b><i>Introduction:</i></b> Protocols for vancomycin de-escalation often rely on nasal swab testing for methicillin-resistant <i>Staphylococcus aureus</i> (MRSA). However, in settings of hospital-wide universal MRSA decolonization with nasal mupirocin, these swabs may be unreliable, hindering de-escalation protocols. This study investigated vancomycin use and MRSA infection in trauma patients managed under each of these separate protocols. <b><i>Methods:</i></b> This retrospective review compared patients admitted to a Level 1 trauma center during a time-period of MRSA swab-based vancomycin de-escalation ("de-esc") with those admitted during a subsequent period of universal decolonization (and thus "no de-esc"). The primary outcome was total days of vancomycin per patient receiving vancomycin. Additional outcomes included a proportion of patients receiving a short course of vancomycin (<3 d), overall vancomycin rates, and in-hospital MRSA infections. <b><i>Results:</i></b> A total of 5,678 patients were evaluated, with 2,891 admitted during the "de-esc" period and 2,787 admitted during universal decolonization ("no de-esc"). There was no difference in the proportion of patients receiving vancomycin during the "de-esc" versus "no de-esc" protocols (7.2% [n = 208] vs. 6.5% [n = 181], p = 0.3). Among these patients, there was also no difference in either total days of vancomycin (5.3 d vs. 5.9 d, p = 0.3) or proportion receiving a short vancomycin course (33% vs. 29%, p = 0.5). There were 56 total patients with MRSA infections, with no difference between the two time periods (1.1% vs. 0.7%, p = 0.07). <b><i>Conclusion:</i></b> Despite concerns that a hospital-wide MRSA universal decolonization policy would hinder nasal swab-based vancomycin de-escalation, both vancomycin use and MRSA infection rates remained the same during the two time periods.

Surgical InfectionsVol. 26(6)
Vanderbilt University Medical Center (US)
Openalex Percentile: Top 91%
Antimicrobial Resistance in Staphylococcus
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.